Reports
Reports
Continuous Glucose Monitoring (CGM) Market is expanding at a very high rate with the fast-rising prevalence of diabetes and demand for efficient management systems. CGM systems provide accurate, real-time information on blood glucose level so that the patient can take proper action on diet, exercise, and insulin therapy. This not only enhances glycemic control but also reduces the risk of complications of diabetes, hence making it a useful tool for both patients and medical practitioners.
.jpg "Continuous Glucose Monitoring Market Revenue Growth (USD Bn)")
The expansion is further fueled by technology breakthroughs like interoperability between smartphone technology and CGM devices and wearable technology. With such alignment, the tracking of glucose is easy for the users, and data transfer to healthcare providers is made easy, paving the way for remote monitoring and customized treatment programs. More emphasis on preventive care and patient empowerment further drive more users to the use of CGM systems.
In addition, clearance of other CGM technologies by the regulatory bodies is providing market opportunities for entry and introducing competition among manufacturers, which will result in innovation and cost reduction. As more people are aware of the benefits of continuous monitoring and increased improvements in device accuracy and ease of use, the market for CGM will expand tremendously, enhancing diabetes control and patient health.
Continuous glucose monitoring (CGM) is a technology that monitors glucose levels continuously during the day and at night. It is a small sensor inserted under the skin, typically on the abdomen or arm, which monitors glucose levels in the interstitial fluid. Data is transferred wirelessly to a receiver or a smartphone application, giving users constant feedback on their glucose trends. These glucose monitoring allows people with diabetes to better control their diabetes by giving them information on how diet, exercise, medications, and other factors affect their glucose levels.
Compared to the traditional finger stick test, continuous glucose monitoring gives a more comprehensive and dynamic view of glucose levels, enabling immediate adjustments in treatment and reducing the potential for hypoglycemia or hyperglycemia. Modern continuous glucose monitoring systems often include user-programmable alarms, which make them valuable tools for improving glucose control and diabetes care in general.
| Attribute | Detail |
|---|---|
| Continuous Glucose Monitoring Market Drivers |
|
The remote patient monitoring and telemedicine markets have influenced the growth of the Continuous Glucose Monitoring (CGM) market in a big way. As healthcare systems gravitate toward more efficient and convenient healthcare, CGM technology provides real-time glucose monitoring, enabling diabetes patients to take care of their condition at home while still being connected to healthcare professionals.
Telemedicine has also accelerated the uptake of CGM, since these devices are readily integrated into telehealth platforms. Clinicians can remotely monitor glucose levels and provide timely intervention and personalized guidance without physical consultation. This improves patient engagement, enhances treatment adherence, and lowers healthcare costs by enabling better outcomes. The pandemic of COVID-19 also hastened demand for remote care, pushing both providers and patients toward virtual solutions.
CGMs provide real-time glucose data that can be examined within the framework of telehealth visits to enable timely planning of care. As technology evolves, CGMs are also becoming less costly and simpler to use, which makes them more accessible. This convergence of remote monitoring and digital health is revolutionizing diabetes care and driving sustained demand in the continuous glucose monitoring industry.
The Continuous Glucose Monitoring (CGM) market is experiencing rapid growth, largely driven by significant technological advancements. Innovations in sensor technology, data analytics, and connectivity are enhancing the accuracy, responsiveness, and usability of CGM systems. Second-generation CGMs now offer more precise readings, faster response times, and longer-lasting sensors, contributing to improved glucose control and patient outcomes.
Modern CGMs also feature real-time data sharing, integration with wearables and smartphones, and customizable alerts for abnormal readings-empowering users to take immediate action. As artificial intelligence and machine learning evolve, CGM platforms can now offer deeper data insights, enabling better trend analysis and more informed decision-making by both patients and clinicians. The shift toward minimally invasive and user-friendly devices has broadened CGM accessibility and appeal.
Continued innovation is expected to introduce predictive capabilities that forecast glucose fluctuations, allowing for proactive diabetes management.As technology improves, CGMs are becoming more affordable and are increasingly integrated into comprehensive diabetes care solutions-solidifying their role in the future of personalized, digital healthcare.
Sensor devices are the core technology driving the Continuous Glucose Monitoring (CGM) market, primarily due to their ability to deliver accurate and timely glucose readings. These sensors enable continuous monitoring with minimal discomfort, making them both effective and user-friendly. Ongoing advancements have improved sensor accuracy, sensitivity, and stability-critical factors in building user trust and enhancing patient experience.
As the demand for better diabetes management grows, so does the need for high-performance sensors. Their ability to provide rapid glucose readings plays a vital role in preventing hypoglycemic and hyperglycemic episodes. The emergence of minimally invasive and implantable sensors has further propelled market growth by offering more comfortable, long-term monitoring options.
Enhanced by sophisticated algorithms and seamless connectivity features, sensors now support real-time data sharing and advanced glucose trend analysis. As a result, the sensor segment remains the dominant force in the CGM market, significantly improving patient outcomes and reinforcing its central role in diabetes care.
| Attribute | Detail |
|---|---|
| Leading Region | North America |
According to the latest continuous glucose monitoring market analysis North America is anticipated to lead the industry because of several reasons. The region is highly impacted by diabetes and has millions of patients requiring tight control. This creates enormous demand for CGM technology, which provides tighter control and less complication for the patient.
A, North America is home to pharma and tech giants that invest heavily in R&D. These companies are driving innovation in CGM systems through continuous innovation in device accuracy, connectivity, and usability. Healthcare infrastructure is also robust in the region along with advanced regulatory systems that facilitate development of the region's market for CGM.
Other than this, growing awareness of the importance of diabetes management and benefits of round-the-clock monitoring of patients as well as caregivers encourages adoption. With such immense focus on patient care and integration with telehealth, North America is going to dominate the CGM market with constant growth and development of diabetes management solutions.
Key players are making efforts to obtain regulatory approvals for new stent technologies. Companies are actively working on getting their products approved by major regulatory bodies like the FDA and EMA, ensuring that their stents meet safety and efficacy standards.
Dexcom, Inc., Abbott, Medtronic, Ypsomed AG, Senseonics Holdings, Inc., A. Menarini Diagnostics S.r.l., Signos, Inc., F. Hoffmann-La Roche Ltd, Nemaura, Bionime Corporation, Intelligo BV. are some of the leading players operating in the Continuous Glucose Monitoring Market industry.
Each of these players has been have been profiled in the Continuous Glucose Monitoring Market research report based on parameters such as company overview, financial overview, business strategies, product portfolio, business segments, and recent developments.
| Attribute | Detail |
|---|---|
| Size in 2024 | US$ 5.8 Bn |
| Forecast Value in 2035 | US$ 12.6 Bn |
| CAGR | 7.4% |
| Forecast Period | 2025-2035 |
| Historical Data Available for | 2020-2023 |
| Quantitative Units | US$ Bn |
| Continuous Glucose Monitoring Market Analysis | It includes segment analysis as well as regional level analysis. Moreover, qualitative analysis includes drivers, restraints, opportunities, key trends, value chain analysis, and key trend analysis. |
| Competition Landscape |
|
| Format | Electronic (PDF) + Excel |
| Segmentation |
|
| Regions Covered |
|
| Countries Covered |
|
| Companies Profiled |
|
| Customization Scope | Available upon request |
| Pricing | Available upon request |
The global continuous glucose monitoring market was valued at US$ 5.8 Bn in 2024.
The global continuous glucose monitoring market is projected to cross US$ 12.6 Bn by the end of 2035.
Growing demand for remote patient monitoring and telemedicine and technological advancements in CGM devices.
The CAGR is anticipated to be 7.4% from 2025 to 2035.
North America is expected to account for the largest share from 2025 to 2035.
Dexcom, Inc., Abbott, Medtronic, Ypsomed AG, Senseonics Holdings, Inc., A. Menarini Diagnostics S.r.l., Signos, Inc., F. Hoffmann-La Roche Ltd, Nemaura, Bionime Corporation, Intelligo BV. And Others.
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Continuous Glucose Monitoring Market
4. Market Overview
4.1. Introduction
4.1.1. Segment Definition
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Continuous Glucose Monitoring Market Analysis and Forecast, 2020 to 2035
4.4.1. Market Revenue Projections (US$ Bn)
5. Key Insights
5.1. Disease Prevalence & Incidence Rate globally with key countries
5.2. Key Industry Events (Mergers, Acquisitions, Partnerships, Collaborations, etc.)
5.3. Technological Advancements
5.4. PORTER’s Five Forces Analysis
5.5. PESTEL Analysis
5.6. Value Chain Analysis
5.7. Pricing Analysis (Brand pricing, Average Selling Price by Region/Country)
5.8. Regulatory Scenario by Key Country/Region
5.9. Research and Development Trends
5.10. Go-to-Market Strategy for New Market Entrants
6. Global Continuous Glucose Monitoring Market Analysis and Forecast, by Type
6.1. Introduction & Definition
6.2. Key Findings/Developments
6.3. Market Value Forecast, by Type, 2020 to 2035
6.3.1. Real-Time CGM
6.3.2. Intermittently Scanned CGM
6.4. Market Attractiveness Analysis, by Type
7. Global Continuous Glucose Monitoring Market Analysis and Forecast, by Component
7.1. Introduction & Definition
7.2. Key Findings/Developments
7.3. Market Value Forecast, by Component, 2020 to 2035
7.3.1. Sensor
7.3.2. Transmitter
7.3.3. Receiver
7.4. Market Attractiveness Analysis, by Component
8. Global Continuous Glucose Monitoring Market Analysis and Forecast, by Age Group
8.1. Introduction & Definition
8.2. Key Findings/Developments
8.3. Market Value Forecast, by Age Group, 2020 to 2035
8.3.1. Children
8.3.2. Adults
8.4. Market Attractiveness Analysis, by Age Group
9. Global Continuous Glucose Monitoring Market Analysis and Forecast, by Indication
9.1. Introduction & Definition
9.2. Key Findings/Developments
9.3. Market Value Forecast, by Indication, 2020 to 2035
9.3.1. Type 1 Diabetes
9.3.2. Type 2 Diabetes
9.3.3. Others
9.4. Market Attractiveness Analysis, by Indication
10. Global Continuous Glucose Monitoring Market Analysis and Forecast, by End-user
10.1. Introduction & Definition
10.2. Key Findings/Developments
10.3. Market Value Forecast, by End-user, 2020 to 2035
10.3.1. Hospitals & Clinics
10.3.2. Homecare Settings
10.3.3. Others
10.4. Market Attractiveness Analysis, by End-user
11. Global Continuous Glucose Monitoring Market Analysis and Forecast, by Region
11.1. Key Findings
11.2. Market Value Forecast, by Region, 2020 to 2035
11.2.1. North America
11.2.2. Europe
11.2.3. Asia Pacific
11.2.4. Latin America
11.2.5. Middle East & Africa
11.3. Market Attractiveness Analysis, by Region
12. North America Continuous Glucose Monitoring Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast, by Type, 2020 to 2035
12.2.1. Real-Time CGM
12.2.2. Intermittently Scanned CGM
12.3. Market Value Forecast, by Component, 2020 to 2035
12.3.1. Sensor
12.3.2. Transmitter
12.3.3. Receiver
12.4. Market Value Forecast, by Age Group, 2020 to 2035
12.4.1. Children
12.4.2. Adults
12.5. Market Value Forecast, by Indication, 2020 to 2035
12.5.1. Type 1 Diabetes
12.5.2. Type 2 Diabetes
12.5.3. Others
12.6. Market Value Forecast, by End-user, 2020 to 2035
12.6.1. Hospitals & Clinics
12.6.2. Homecare Settings
12.6.3. Others
12.7. Market Value Forecast, by Country, 2020 to 2035
12.7.1. U.S.
12.7.2. Canada
12.8. Market Attractiveness Analysis
12.8.1. By Type
12.8.2. By Component
12.8.3. By Age Group
12.8.4. By Indication
12.8.5. By End-user
12.8.6. By Country
13. Europe Continuous Glucose Monitoring Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast, by Type, 2020 to 2035
13.2.1. Real-Time CGM
13.2.2. Intermittently Scanned CGM
13.3. Market Value Forecast, by Component, 2020 to 2035
13.3.1. Sensor
13.3.2. Transmitter
13.3.3. Receiver
13.4. Market Value Forecast, by Age Group, 2020 to 2035
13.4.1. Children
13.4.2. Adults
13.5. Market Value Forecast, by Indication, 2020 to 2035
13.5.1. Type 1 Diabetes
13.5.2. Type 2 Diabetes
13.5.3. Others
13.6. Market Value Forecast, by End-user, 2020 to 2035
13.6.1. Hospitals & Clinics
13.6.2. Homecare Settings
13.6.3. Others
13.7. Market Value Forecast, by Country/Sub-region, 2020 to 2035
13.7.1. Germany
13.7.2. UK
13.7.3. France
13.7.4. Italy
13.7.5. Spain
13.7.6. The Netherlands
13.7.7. Switzerland
13.7.8. Rest of Europe
13.8. Market Attractiveness Analysis
13.8.1. By Type
13.8.2. By Component
13.8.3. By Age Group
13.8.4. By Indication
13.8.5. By End-user
13.8.6. By Country/Sub-region
14. Asia Pacific Continuous Glucose Monitoring Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Market Value Forecast, by Type, 2020 to 2035
14.2.1. Real-Time CGM
14.2.2. Intermittently Scanned CGM
14.3. Market Value Forecast, by Component, 2020 to 2035
14.3.1. Sensor
14.3.2. Transmitter
14.3.3. Receiver
14.4. Market Value Forecast, by Age Group, 2020 to 2035
14.4.1. Children
14.4.2. Adults
14.5. Market Value Forecast, by Indication, 2020 to 2035
14.5.1. Type 1 Diabetes
14.5.2. Type 2 Diabetes
14.5.3. Others
14.6. Market Value Forecast, by End-user, 2020 to 2035
14.6.1. Hospitals & Clinics
14.6.2. Homecare Settings
14.6.3. Others
14.7. Market Value Forecast, by Country/Sub-region, 2020 to 2035
14.7.1. China
14.7.2. Japan
14.7.3. India
14.7.4. Australia & New Zealand
14.7.5. South Korea
14.7.6. Rest of Asia Pacific
14.8. Market Attractiveness Analysis
14.8.1. By Type
14.8.2. By Component
14.8.3. By Age Group
14.8.4. By Indication
14.8.5. By End-user
14.8.6. By Country/Sub-region
15. Latin America Continuous Glucose Monitoring Market Analysis and Forecast
15.1. Introduction
15.1.1. Key Findings
15.2. Market Value Forecast, by Type, 2020 to 2035
15.2.1. Real-Time CGM
15.2.2. Intermittently Scanned CGM
15.3. Market Value Forecast, by Component, 2020 to 2035
15.3.1. Sensor
15.3.2. Transmitter
15.3.3. Receiver
15.4. Market Value Forecast, by Age Group, 2020 to 2035
15.4.1. Children
15.4.2. Adults
15.5. Market Value Forecast, by Indication, 2020 to 2035
15.5.1. Type 1 Diabetes
15.5.2. Type 2 Diabetes
15.5.3. Others
15.6. Market Value Forecast, by End-user, 2020 to 2035
15.6.1. Hospitals & Clinics
15.6.2. Homecare Settings
15.6.3. Others
15.7. Market Value Forecast, by Country/Sub-region, 2020 to 2035
15.7.1. Brazil
15.7.2. Mexico
15.7.3. Argentina
15.7.4. Rest of Latin America
15.8. Market Attractiveness Analysis
15.8.1. By Type
15.8.2. By Component
15.8.3. By Age Group
15.8.4. By Indication
15.8.5. By End-user
15.8.6. By Country/Sub-region
16. Middle East & Africa Continuous Glucose Monitoring Market Analysis and Forecast
16.1. Introduction
16.1.1. Key Findings
16.2. Market Value Forecast, by Type, 2020 to 2035
16.2.1. Real-Time CGM
16.2.2. Intermittently Scanned CGM
16.3. Market Value Forecast, by Component, 2020 to 2035
16.3.1. Sensor
16.3.2. Transmitter
16.3.3. Receiver
16.4. Market Value Forecast, by Age Group, 2020 to 2035
16.4.1. Children
16.4.2. Adults
16.5. Market Value Forecast, by Indication, 2020 to 2035
16.5.1. Type 1 Diabetes
16.5.2. Type 2 Diabetes
16.5.3. Others
16.6. Market Value Forecast, by End-user, 2020 to 2035
16.6.1. Hospitals & Clinics
16.6.2. Homecare Settings
16.6.3. Others
16.7. Market Value Forecast, by Country/Sub-region, 2020 to 2035
16.7.1. GCC Countries
16.7.2. South Africa
16.7.3. Rest of Middle East & Africa
16.8. Market Attractiveness Analysis
16.8.1. By Type
16.8.2. By Component
16.8.3. By Age Group
16.8.4. By Indication
16.8.5. By End-user
16.8.6. By Country/Sub-region
17. Competition Landscape
17.1. Market Player – Competition Matrix (By Tier and Size of Companies)
17.2. Market Share Analysis, by Company (2024)
17.3. Company Profiles
17.3.1. Dexcom, Inc.
17.3.1.1. Company Overview
17.3.1.2. Financial Overview
17.3.1.3. Product Portfolio
17.3.1.4. Business Strategies
17.3.1.5. Recent Developments
17.3.2. Abbott
17.3.2.1. Company Overview
17.3.2.2. Financial Overview
17.3.2.3. Product Portfolio
17.3.2.4. Business Strategies
17.3.2.5. Recent Developments
17.3.3. Medtronic
17.3.3.1. Company Overview
17.3.3.2. Financial Overview
17.3.3.3. Product Portfolio
17.3.3.4. Business Strategies
17.3.3.5. Recent Developments
17.3.4. Ypsomed AG
17.3.4.1. Company Overview
17.3.4.2. Financial Overview
17.3.4.3. Product Portfolio
17.3.4.4. Business Strategies
17.3.4.5. Recent Developments
17.3.5. Senseonics Holdings, Inc.
17.3.5.1. Company Overview
17.3.5.2. Financial Overview
17.3.5.3. Product Portfolio
17.3.5.4. Business Strategies
17.3.5.5. Recent Developments
17.3.6. A. Menarini Diagnostics S.r.l.
17.3.6.1. Company Overview
17.3.6.2. Financial Overview
17.3.6.3. Product Portfolio
17.3.6.4. Business Strategies
17.3.6.5. Recent Developments
17.3.7. Signos, Inc.
17.3.7.1. Company Overview
17.3.7.2. Financial Overview
17.3.7.3. Product Portfolio
17.3.7.4. Business Strategies
17.3.7.5. Recent Developments
17.3.8. F. Hoffmann-La Roche Ltd
17.3.8.1. Company Overview
17.3.8.2. Financial Overview
17.3.8.3. Product Portfolio
17.3.8.4. Business Strategies
17.3.8.5. Recent Developments
17.3.9. Nemaura
17.3.9.1. Company Overview
17.3.9.2. Financial Overview
17.3.9.3. Product Portfolio
17.3.9.4. Business Strategies
17.3.9.5. Recent Developments
17.3.10. Bionime Corporation
17.3.10.1. Company Overview
17.3.10.2. Financial Overview
17.3.10.3. Product Portfolio
17.3.10.4. Business Strategies
17.3.10.5. Recent Developments
17.3.11. Intelligo BV.
17.3.11.1. Company Overview
17.3.11.2. Financial Overview
17.3.11.3. Product Portfolio
17.3.11.4. Business Strategies
17.3.11.5. Recent Developments
List of Tables
Table 01: Global Continuous Glucose Monitoring Market Value (US$ Bn) Forecast, By Type, 2020 to 2035
Table 02: Global Continuous Glucose Monitoring Market Value (US$ Bn) Forecast, By Component, 2020 to 2035
Table 03: Global Continuous Glucose Monitoring Market Value (US$ Bn) Forecast, By Age Group, 2020 to 2035
Table 04: Global Continuous Glucose Monitoring Market Value (US$ Bn) Forecast, By Indication, 2020 to 2035
Table 05: Global Continuous Glucose Monitoring Market Value (US$ Bn) Forecast, By End-user, 2020 to 2035
Table 06: Global Continuous Glucose Monitoring Market Value (US$ Bn) Forecast, By Region, 2020 to 2035
Table 07: North America Continuous Glucose Monitoring Market Value (US$ Bn) Forecast, by Country, 2020 to 2035
Table 08: North America Continuous Glucose Monitoring Market Value (US$ Bn) Forecast, By Type, 2020 to 2035
Table 09: North America Continuous Glucose Monitoring Market Value (US$ Bn) Forecast, By Component, 2020 to 2035
Table 10: North America Continuous Glucose Monitoring Market Value (US$ Bn) Forecast, By Age Group, 2020 to 2035
Table 11: North America Continuous Glucose Monitoring Market Value (US$ Bn) Forecast, By Indication, 2020 to 2035
Table 12: North America Continuous Glucose Monitoring Market Value (US$ Bn) Forecast, By End-user, 2020 to 2035
Table 13: Europe Continuous Glucose Monitoring Market Value (US$ Bn) Forecast, by Country / Sub-region, 2020 to 2035
Table 14: Europe Continuous Glucose Monitoring Market Value (US$ Bn) Forecast, By Type, 2020 to 2035
Table 15: Europe Continuous Glucose Monitoring Market Value (US$ Bn) Forecast, By Component, 2020 to 2035
Table 16: Europe Continuous Glucose Monitoring Market Value (US$ Bn) Forecast, By Age Group, 2020 to 2035
Table 17: Europe Continuous Glucose Monitoring Market Value (US$ Bn) Forecast, By Indication, 2020 to 2035
Table 18: Europe Continuous Glucose Monitoring Market Value (US$ Bn) Forecast, By End-user, 2020 to 2035
Table 19: Asia Pacific Continuous Glucose Monitoring Market Value (US$ Bn) Forecast, by Country / Sub-region, 2020 to 2035
Table 20: Asia Pacific Continuous Glucose Monitoring Market Value (US$ Bn) Forecast, By Type, 2020 to 2035
Table 21: Asia Pacific Continuous Glucose Monitoring Market Value (US$ Bn) Forecast, By Component, 2020 to 2035
Table 22: Asia Pacific Continuous Glucose Monitoring Market Value (US$ Bn) Forecast, By Age Group, 2020 to 2035
Table 23: Asia Pacific Continuous Glucose Monitoring Market Value (US$ Bn) Forecast, By Indication, 2020 to 2035
Table 24: Asia Pacific Continuous Glucose Monitoring Market Value (US$ Bn) Forecast, By End-user, 2020 to 2035
Table 25: Latin America Continuous Glucose Monitoring Market Value (US$ Bn) Forecast, by Country / Sub-region, 2020 to 2035
Table 26: Latin America Continuous Glucose Monitoring Market Value (US$ Bn) Forecast, By Type, 2020 to 2035
Table 27: Latin America Continuous Glucose Monitoring Market Value (US$ Bn) Forecast, By Component, 2020 to 2035
Table 28: Latin America Continuous Glucose Monitoring Market Value (US$ Bn) Forecast, By Age Group, 2020 to 2035
Table 29: Latin America Continuous Glucose Monitoring Market Value (US$ Bn) Forecast, By Indication, 2020 to 2035
Table 30: Latin America Continuous Glucose Monitoring Market Value (US$ Bn) Forecast, By End-user, 2020 to 2035
Table 31: Middle East & Africa Continuous Glucose Monitoring Market Value (US$ Bn) Forecast, by Country / Sub-region, 2020 to 2035
Table 32: Middle East & Africa Continuous Glucose Monitoring Market Value (US$ Bn) Forecast, By Type, 2020 to 2035
Table 33: Middle East & Africa Continuous Glucose Monitoring Market Value (US$ Bn) Forecast, By Component, 2020 to 2035
Table 34: Middle East & Africa Continuous Glucose Monitoring Market Value (US$ Bn) Forecast, By Age Group, 2020 to 2035
Table 35: Middle East & Africa Continuous Glucose Monitoring Market Value (US$ Bn) Forecast, By Indication, 2020 to 2035
Table 36: Middle East & Africa Continuous Glucose Monitoring Market Value (US$ Bn) Forecast, By End-user, 2020 to 2035
List of Figures
Figure 01: Global Continuous Glucose Monitoring Market Value Share Analysis, By Type, 2024 and 2035
Figure 02: Global Continuous Glucose Monitoring Market Attractiveness Analysis, By Type, 2025 to 2035
Figure 03: Global Continuous Glucose Monitoring Market Revenue (US$ Bn), by Real-Time CGM, 2020 to 2035
Figure 04: Global Continuous Glucose Monitoring Market Revenue (US$ Bn), by Intermittently Scanned CGM, 2020 to 2035
Figure 05: Global Continuous Glucose Monitoring Market Value Share Analysis, By Component, 2024 and 2035
Figure 06: Global Continuous Glucose Monitoring Market Attractiveness Analysis, By Component, 2025 to 2035
Figure 07: Global Continuous Glucose Monitoring Market Revenue (US$ Bn), by Sensor, 2020 to 2035
Figure 08: Global Continuous Glucose Monitoring Market Revenue (US$ Bn), by Transmitter, 2020 to 2035
Figure 09: Global Continuous Glucose Monitoring Market Revenue (US$ Bn), by Receiver, 2020 to 2035
Figure 10: Global Continuous Glucose Monitoring Market Value Share Analysis, By Age Group, 2024 and 2035
Figure 11: Global Continuous Glucose Monitoring Market Attractiveness Analysis, By Age Group, 2025 to 2035
Figure 12: Global Continuous Glucose Monitoring Market Revenue (US$ Bn), by Children, 2020 to 2035
Figure 13: Global Continuous Glucose Monitoring Market Revenue (US$ Bn), by Adults, 2020 to 2035
Figure 14: Global Continuous Glucose Monitoring Market Value Share Analysis, By Indication, 2024 and 2035
Figure 15: Global Continuous Glucose Monitoring Market Attractiveness Analysis, By Indication, 2025 to 2035
Figure 16: Global Continuous Glucose Monitoring Market Revenue (US$ Bn), by Type 1 Diabetes, 2020 to 2035
Figure 17: Global Continuous Glucose Monitoring Market Revenue (US$ Bn), by Type 2 Diabetes, 2020 to 2035
Figure 18: Global Continuous Glucose Monitoring Market Revenue (US$ Bn), by Others, 2020 to 2035
Figure 19: Global Continuous Glucose Monitoring Market Value Share Analysis, By End-user, 2024 and 2035
Figure 20: Global Continuous Glucose Monitoring Market Attractiveness Analysis, By End-user, 2025 to 2035
Figure 21: Global Continuous Glucose Monitoring Market Revenue (US$ Bn), by Hospitals & Clinics, 2020 to 2035
Figure 22: Global Continuous Glucose Monitoring Market Revenue (US$ Bn), by Homecare Settings, 2020 to 2035
Figure 23: Global Continuous Glucose Monitoring Market Revenue (US$ Bn), by Others, 2020 to 2035
Figure 24: Global Continuous Glucose Monitoring Market Value Share Analysis, By Region, 2024 and 2035
Figure 25: Global Continuous Glucose Monitoring Market Attractiveness Analysis, By Region, 2025 to 2035
Figure 26: North America Continuous Glucose Monitoring Market Value (US$ Bn) Forecast, 2020 to 2035
Figure 27: North America Continuous Glucose Monitoring Market Value Share Analysis, by Country, 2024 and 2035
Figure 28: North America Continuous Glucose Monitoring Market Attractiveness Analysis, by Country, 2025 to 2035
Figure 29: North America Continuous Glucose Monitoring Market Value Share Analysis, By Type, 2024 and 2035
Figure 30: North America Continuous Glucose Monitoring Market Attractiveness Analysis, By Type, 2025 to 2035
Figure 31: North America Continuous Glucose Monitoring Market Value Share Analysis, By Component, 2024 and 2035
Figure 32: North America Continuous Glucose Monitoring Market Attractiveness Analysis, By Component, 2025 to 2035
Figure 33: North America Continuous Glucose Monitoring Market Value Share Analysis, By Age Group, 2024 and 2035
Figure 34: North America Continuous Glucose Monitoring Market Attractiveness Analysis, By Age Group, 2025 to 2035
Figure 35: North America Continuous Glucose Monitoring Market Value Share Analysis, By Indication, 2024 and 2035
Figure 36: North America Continuous Glucose Monitoring Market Attractiveness Analysis, By Indication, 2025 to 2035
Figure 37: North America Continuous Glucose Monitoring Market Value Share Analysis, By End-user, 2024 and 2035
Figure 38: North America Continuous Glucose Monitoring Market Attractiveness Analysis, By End-user, 2025 to 2035
Figure 39: Europe Continuous Glucose Monitoring Market Value (US$ Bn) Forecast, 2020 to 2035
Figure 40: Europe Continuous Glucose Monitoring Market Value Share Analysis, by Country / Sub-region, 2024 and 2035
Figure 41: Europe Continuous Glucose Monitoring Market Attractiveness Analysis, by Country / Sub-region, 2025 to 2035
Figure 42: Europe Continuous Glucose Monitoring Market Value Share Analysis, By Type, 2024 and 2035
Figure 43: Europe Continuous Glucose Monitoring Market Attractiveness Analysis, By Type, 2025 to 2035
Figure 44: Europe Continuous Glucose Monitoring Market Value Share Analysis, By Component, 2024 and 2035
Figure 45: Europe Continuous Glucose Monitoring Market Attractiveness Analysis, By Component, 2025 to 2035
Figure 46: Europe Continuous Glucose Monitoring Market Value Share Analysis, By Age Group, 2024 and 2035
Figure 47: Europe Continuous Glucose Monitoring Market Attractiveness Analysis, By Age Group, 2025 to 2035
Figure 48: Europe Continuous Glucose Monitoring Market Value Share Analysis, By Indication, 2024 and 2035
Figure 49: Europe Continuous Glucose Monitoring Market Attractiveness Analysis, By Indication, 2025 to 2035
Figure 50: Europe Continuous Glucose Monitoring Market Value Share Analysis, By End-user, 2024 and 2035
Figure 51: Europe Continuous Glucose Monitoring Market Attractiveness Analysis, By End-user, 2025 to 2035
Figure 52: Asia Pacific Continuous Glucose Monitoring Market Value (US$ Bn) Forecast, 2020 to 2035
Figure 53: Asia Pacific Continuous Glucose Monitoring Market Value Share Analysis, by Country/Sub-region, 2024 and 2035
Figure 54: Asia Pacific Continuous Glucose Monitoring Market Attractiveness Analysis, by Country/Sub-region, 2025 to 2035
Figure 55: Asia Pacific Continuous Glucose Monitoring Market Value Share Analysis, By Type, 2024 and 2035
Figure 56: Asia Pacific Continuous Glucose Monitoring Market Attractiveness Analysis, By Type, 2025 to 2035
Figure 57: Asia Pacific Continuous Glucose Monitoring Market Value Share Analysis, By Component, 2024 and 2035
Figure 58: Asia Pacific Continuous Glucose Monitoring Market Attractiveness Analysis, By Component, 2025 to 2035
Figure 59: Asia Pacific Continuous Glucose Monitoring Market Value Share Analysis, By Age Group, 2024 and 2035
Figure 60: Asia Pacific Continuous Glucose Monitoring Market Attractiveness Analysis, By Age Group, 2025 to 2035
Figure 61: Asia Pacific Continuous Glucose Monitoring Market Value Share Analysis, By Indication, 2024 and 2035
Figure 62: Asia Pacific Continuous Glucose Monitoring Market Attractiveness Analysis, By Indication, 2025 to 2035
Figure 63: Asia Pacific Continuous Glucose Monitoring Market Value Share Analysis, By End-user, 2024 and 2035
Figure 64: Asia Pacific Continuous Glucose Monitoring Market Attractiveness Analysis, By End-user, 2025 to 2035
Figure 65: Latin America Continuous Glucose Monitoring Market Value (US$ Bn) Forecast, 2020 to 2035
Figure 66: Latin America Continuous Glucose Monitoring Market Value Share Analysis, by Country / Sub-region, 2024 and 2035
Figure 67: Latin America Continuous Glucose Monitoring Market Attractiveness Analysis, by Country / Sub-region, 2025 to 2035
Figure 68: Latin America Continuous Glucose Monitoring Market Value Share Analysis, By Type, 2024 and 2035
Figure 69: Latin America Continuous Glucose Monitoring Market Attractiveness Analysis, By Type, 2025 to 2035
Figure 70: Latin America Continuous Glucose Monitoring Market Value Share Analysis, By Component, 2024 and 2035
Figure 71: Latin America Continuous Glucose Monitoring Market Attractiveness Analysis, By Component, 2025 to 2035
Figure 72: Latin America Continuous Glucose Monitoring Market Value Share Analysis, By Age Group, 2024 and 2035
Figure 73: Latin America Continuous Glucose Monitoring Market Attractiveness Analysis, By Age Group, 2025 to 2035
Figure 74: Latin America Continuous Glucose Monitoring Market Value Share Analysis, By Indication, 2024 and 2035
Figure 75: Latin America Continuous Glucose Monitoring Market Attractiveness Analysis, By Indication, 2025 to 2035
Figure 76: Latin America Continuous Glucose Monitoring Market Value Share Analysis, By End-user, 2024 and 2035
Figure 77: Latin America Continuous Glucose Monitoring Market Attractiveness Analysis, By End-user, 2025 to 2035
Figure 78: Middle East & Africa Continuous Glucose Monitoring Market Value (US$ Bn) Forecast, 2020 to 2035
Figure 79: Middle East & Africa Continuous Glucose Monitoring Market Value Share Analysis, by Country / Sub-region, 2024 and 2035
Figure 80: Middle East & Africa Continuous Glucose Monitoring Market Attractiveness Analysis, by Country / Sub-region, 2025 to 2035
Figure 81: Middle East & Africa Continuous Glucose Monitoring Market Value Share Analysis, By Type, 2024 and 2035
Figure 82: Middle East & Africa Continuous Glucose Monitoring Market Attractiveness Analysis, By Type, 2025 to 2035
Figure 83: Middle East & Africa Continuous Glucose Monitoring Market Value Share Analysis, By Component, 2024 and 2035
Figure 84: Middle East & Africa Continuous Glucose Monitoring Market Attractiveness Analysis, By Component, 2025 to 2035
Figure 85: Middle East & Africa Continuous Glucose Monitoring Market Value Share Analysis, By Age Group, 2024 and 2035
Figure 86: Middle East & Africa Continuous Glucose Monitoring Market Attractiveness Analysis, By Age Group, 2025 to 2035
Figure 87: Middle East & Africa Continuous Glucose Monitoring Market Value Share Analysis, By Indication, 2024 and 2035
Figure 88: Middle East & Africa Continuous Glucose Monitoring Market Attractiveness Analysis, By Indication, 2025 to 2035
Figure 89: Middle East & Africa Continuous Glucose Monitoring Market Value Share Analysis, By End-user, 2024 and 2035
Figure 90: Middle East & Africa Continuous Glucose Monitoring Market Attractiveness Analysis, By End-user, 2025 to 2035
Copyright © Transparency Market Research, Inc. All Rights reserved
Trust Online
Continuous Glucose Monitoring Market